As mentioned above, the expression of UBE2S and UBE2C was decreased and Numb was increased in ER+ breast cancer; we thus explored the prognostic values of UBE2S, UBE2C, and Numb in ER+ breast cancer patients. This evidence concerns the gene UBE2C and breast cancer.